Crispr Therapeutics AG, created in 2000 (Switzerland), from 2214 competing brands. Crispr Therapeutics AG is owned by Crispr Therapeutics AG, listed on the stock exchange of New York The ISIN, the company's International Securities Identification Number, is CH0334081137. Crispr Therapeutics AG belongs to the Biotechnology business sector.

Crispr Therapeutics AG is a brand of Crispr Therapeutics AG (CRSP) Share price

Date created : 2000 Business sector Biotechnology

Share price and profitability of the share Crispr Therapeutics AG (Crispr Therapeutics AG)

Buy Crispr Therapeutics AG share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 56.50

Portfolio valuation
Crispr Therapeutics AG over 5 years* USD 83.47

Stock market history Crispr Therapeutics AG

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
Crispr Therapeutics AG

See more brands of Crispr Therapeutics AG

Rival brands
Crispr Therapeutics AG

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS